-+ 0.00%
-+ 0.00%
-+ 0.00%

Sagimet Biosciences Q4 EPS $(0.29) Beats $(0.48) Estimate

Benzinga·03/11/2026 11:36:10
Listen to the news
Sagimet Biosciences (NASDAQ:SGMT) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.48) by 39.08 percent. This is a 42 percent increase over losses of $(0.50) per share from the same period last year.